Invention Grant
- Patent Title: Anti CEACAM1 antibodies and methods of using same
- Patent Title (中): 抗CEACAM1抗体及其使用方法
-
Application No.: US14061277Application Date: 2013-10-23
-
Publication No.: US09261507B2Publication Date: 2016-02-16
- Inventor: Gal Markel , Rona Ortenberg , Jacob Schachter
- Applicant: TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. , RAMOT AT TEL AVIV UNIVERSITY LTD.
- Applicant Address: IL Ramat-Gan IL Tel Aviv
- Assignee: Tel Hashomer Medical Research Infrastructure and Services LTD.,RAMOT AT TEL AVIV UNIVERSITY LTD.
- Current Assignee: Tel Hashomer Medical Research Infrastructure and Services LTD.,RAMOT AT TEL AVIV UNIVERSITY LTD.
- Current Assignee Address: IL Ramat-Gan IL Tel Aviv
- Agency: Rothwell, Figg, Ernst & Manbeck PC
- Main IPC: G01N33/574
- IPC: G01N33/574 ; C07K16/28 ; A61K39/00
Abstract:
A method for diagnosing a cancer characterized by over expression of CEACAM1 using an anti-CEACAM1 antibody or antibody fragment that recognizes CEACAM1 and comprises the same CDR sequences in the same orientation as the CDRs of the antibody produced from a hybridoma cell which has been deposited under ATCC Accession Number PTA-9974.
Public/Granted literature
- US20140120554A1 ANTI CEACAM1 ANTIBODIES AND METHODS OF USING SAME Public/Granted day:2014-05-01
Information query
IPC分类:
